Search Results - "KAUFMAN, Francine R"

Threshold-Based Insulin-Pump Interruption for Reduction of Hypoglycemia by Bergenstal, Richard M, Klonoff, David C, Garg, Satish K, Bode, Bruce W, Meredith, Melissa, Slover, Robert H, Ahmann, Andrew J, Welsh, John B, Lee, Scott W, Kaufman, Francine R

“…In this study involving patients with type 1 diabetes, sensor-augmented insulin-pump therapy plus automated insulin suspension when glucose dropped below 70 mg…”
Get full text

Retrospective Analysis of 3-Month Real-World Glucose Data After the MiniMed 670G System Commercial Launch by Stone, Michael P, Agrawal, Pratik, Chen, Xiaoxiao, Liu, Margaret, Shin, John, Cordero, Toni L, Kaufman, Francine R

“…Real-world data from the first 3141 patients who completed 3 months of SmartGuard™ Auto Mode-enabled MiniMed™ 670G system use during the MiniMed 670G System…”
Get more information

Prevention and Treatment of Pediatric Obesity: An Endocrine Society Clinical Practice Guideline Based on Expert Opinion by August, Gilbert P., Caprio, Sonia, Fennoy, Ilene, Freemark, Michael, Kaufman, Francine R., Lustig, Robert H., Silverstein, Janet H., Speiser, Phyllis W., Styne, Dennis M., Montori, Victor M.

“…Objective: Our objective was to formulate practice guidelines for the treatment and prevention of pediatric obesity. Conclusions: We recommend defining…”
Get full text

Effectiveness of Automated Insulin Management Features of the MiniMed ® 640G Sensor-Augmented Insulin Pump by Zhong, Alex, Choudhary, Pratik, McMahon, Chantal, Agrawal, Pratik, Welsh, John B, Cordero, Toni L, Kaufman, Francine R

“…Automated insulin management features of the MiniMed 640G sensor-augmented pump system include suspension in response to predicted low sensor glucose (SG)…”
Get more information

Evaluation of a Predictive Low-Glucose Management System In-Clinic by Buckingham, Bruce A, Bailey, Timothy S, Christiansen, Mark, Garg, Satish, Weinzimer, Stuart, Bode, Bruce, Anderson, Stacey M, Brazg, Ronald, Ly, Trang T, Kaufman, Francine R

“…Predictions based on continuous glucose monitoring (CGM) data are the basis for automatic suspension and resumption of insulin delivery by a predictive…”
Get more information

Reduction in duration of hypoglycemia by automatic suspension of insulin delivery: the in-clinic ASPIRE study by Garg, Satish, Brazg, Ronald L, Bailey, Timothy S, Buckingham, Bruce A, Slover, Robert H, Klonoff, David C, Shin, John, Welsh, John B, Kaufman, Francine R

“…The efficacy of automatic suspension of insulin delivery in induced hypoglycemia among subjects with type 1 diabetes was evaluated. In this randomized…”
Get more information

Retrospective analysis of the real-world use of the threshold suspend feature of sensor-augmented insulin pumps by Agrawal, Pratik, Zhong, Alex, Welsh, John B, Shah, Rajiv, Kaufman, Francine R

“…The automatic Threshold Suspend (TS) feature of the MiniMed 530G system (Medtronic MiniMed, Inc., Northridge, CA), when enabled, suspends insulin delivery for…”
Get more information

Safety of a Hybrid Closed-Loop Insulin Delivery System in Patients With Type 1 Diabetes by Bergenstal, Richard M, Garg, Satish, Weinzimer, Stuart A, Buckingham, Bruce A, Bode, Bruce W, Tamborlane, William V, Kaufman, Francine R

Get full text

A Pilot Trial in Pediatrics with the Sensor-Augmented Pump: Combining Real-Time Continuous Glucose Monitoring with the Insulin Pump by Halvorson, Mary, RN, MSN, CDE, Carpenter, Sue, BA, RN, CDE, Kaiserman, Kevin, MD, Kaufman, Francine R., MD

“…Real-time continuous glucose monitoring and the insulin pump have been combined into the Sensor-Augmented Pump system (Medtronic MiniMed, Northridge, CA). This…”
Get full text

979-P: Glycemic Improvements in CGM-Naïve Patients during SMBG and Implantable CGM Use by TWEDEN, KATHERINE S., ROMAROWSKI, BEN, MDINGI, COLLEEN, KAUFMAN, FRANCINE R.

“…Background: Multiple pivotal and post market studies have confirmed the safety and accuracy of implantable Eversense CGM Systems. A post market study was…”
Get full text

Severe Obesity and Selected Risk Factors in a Sixth Grade Multiracial Cohort: The HEALTHY Study by Marcus, Marsha D., Ph.D, Baranowski, Tom, Ph.D, DeBar, Lynn L., Ph.D., M.P.H, Edelstein, Sharon, Sc.M, Kaufman, Francine R., M.D, Schneider, Margaret, Ph.D, Siega-Riz, Anna Maria, Ph.D., R.D, Staten, Myrlene A., M.D, Virus, Amy, R.D, Yin, Zenong, Ph.D

“…Abstract The purpose of this study was to document the prevalence of severe obesity and associated risk in the HEALTHY cohort. A total of 6,365 students were…”
Get full text

Glucose Outcomes with the In-Home Use of a Hybrid Closed-Loop Insulin Delivery System in Adolescents and Adults with Type 1 Diabetes by Garg, Satish K, Weinzimer, Stuart A, Tamborlane, William V, Buckingham, Bruce A, Bode, Bruce W, Bailey, Timothy S, Brazg, Ronald L, Ilany, Jacob, Slover, Robert H, Anderson, Stacey M, Bergenstal, Richard M, Grosman, Benyamin, Roy, Anirban, Cordero, Toni L, Shin, John, Lee, Scott W, Kaufman, Francine R

“…The safety and effectiveness of the in-home use of a hybrid closed-loop (HCL) system that automatically increases, decreases, and suspends insulin delivery in…”
Get more information

Characteristics of Adolescents and Youth with Recent-Onset Type 2 Diabetes: The TODAY Cohort at Baseline by Copeland, Kenneth C, Zeitler, Philip, Geffner, Mitchell, Guandalini, Cindy, Higgins, Janine, Hirst, Kathryn, Kaufman, Francine R, Linder, Barbara, Marcovina, Santica, McGuigan, Paul, Pyle, Laura, Tamborlane, William, Willi, Steven

“…Context: The Treatment Options for Type 2 Diabetes in Adolescents and Youth (TODAY) cohort represents the largest and best-characterized national sample of…”
Get full text

Safety Evaluation of the MiniMed 670G System in Children 7-13 Years of Age with Type 1 Diabetes by Forlenza, Gregory P, Pinhas-Hamiel, Orit, Liljenquist, David R, Shulman, Dorothy I, Bailey, Timothy S, Bode, Bruce W, Wood, Michael A, Buckingham, Bruce A, Kaiserman, Kevin B, Shin, John, Huang, Suiying, Lee, Scott W, Kaufman, Francine R

“…To evaluate the safety of in-home use of the MiniMed™ 670G system with SmartGuard™ technology in children with type 1 diabetes (T1D). Participants (N = 105,…”
Get more information

Real-World Data from the First U.S. Commercial Users of an Implantable Continuous Glucose Sensor by Sanchez, Patricia, Ghosh-Dastidar, Samanwoy, Tweden, Katherine S, Kaufman, Francine R

“…The Eversense Continuous Glucose Monitoring (CGM) System, with the first 90-day implantable sensor, received FDA (Food and Drug Administration) approval in…”
Get more information

Evaluation of Accuracy and Safety of the Next-Generation Up to 180-Day Long-Term Implantable Eversense Continuous Glucose Monitoring System: The PROMISE Study by Garg, Satish K, Liljenquist, David, Bode, Bruce, Christiansen, Mark P, Bailey, Timothy S, Brazg, Ronald L, Denham, Douglas S, Chang, Anna R, Akturk, Halis Kaan, Dehennis, Andrew, Tweden, Katherine S, Kaufman, Francine R

“…Use of continuous glucose monitoring (CGM) systems is being rapidly adopted as standard of care for insulin-requiring patients with diabetes. The PROMISE study…”
Get more information

655-P: Evaluation of Accuracy and Longevity of an Implantable CGM System through 365 Days by JACQUIN, ARNAUD E., AL-KHAWI, LUJAIN, SANCHEZ, PATRICIA, MOHANTY, SANAT, TWEDEN, KATHERINE S., KAUFMAN, FRANCINE R.

“…Background: The PROMISE Clinical Trial, conducted to assess safety and accuracy of a 180-day implantable CGM System, had 43 subjects implanted with a modified…”
Get full text

656-P: Effect of Calibration Frequency on Accuracy of a 180-Day Implantable CGM System by JACQUIN, ARNAUD E., AL-KHAWI, LUJAIN, GHOSH-DASTIDAR, SAMANWOY, TWEDEN, KATHERINE S., KAUFMAN, FRANCINE R.

“…Background: The PROMISE Clinical Study was conducted to determine the accuracy and safety of the next generation implantable CGM System. A subset of 43…”
Get full text

Device profile of the eversense continuous glucose monitoring system for glycemic control in type-1 diabetes: overview of its safety and efficacy by Irace, Concetta, Cutruzzolà, Antonio, Tweden, Katherine, Kaufman, Francine R

“…Continuous glucose monitoring (CGM) systems offer real-time data to facilitate diabetes management. The novel Eversense CGM has been approved in Europe and the…”
Get more information

Influence of Race, Ethnicity, and Culture on Childhood Obesity: Implications for Prevention and Treatment: A consensus statement of Shaping America's Health and the Obesity Society by Caprio, Sonia, Daniels, Stephen R, Drewnowski, Adam, Kaufman, Francine R, Palinkas, Lawrence A, Rosenbloom, Arlan L, Schwimmer, Jeffrey B

“…Although childhood obesity is increasing in all ethnic and racial groups, its prevalence is higher in nonwhite populations. The reasons for the differences in…”
Get full text